Thus, as with the 2007 analysis,
the proportion of truly synthetic (i.e., devoid of natural
product inspiration and coded as S) is still at 37%. In
considering disease categories, 68.3% of anti-infectives (antibacterials,
-fungal, -parasitic, and -viral) were classified as
naturally derived or inspired (N; ND; S*; S*/NM; S/NM),
while in the cancer treatment area, 79.8% were in these
categories, with the figure dropping to 62.9% if the S/NM
category is excluded.